Chemotherapy, immunity and microbiota—a new triumvirate?

Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong, Jin Ye, Lei Song, Yunzhi Wang, Qingqing Li, Benjie Shan, Yi‐Zhou Jiang, Hongqi Li, Zhi-Ming Shao, Guido Guido Kroemer, Huafeng Zhang, Li Bai, Tengchuan Jin, Chao Wang, Yuting Ma, Yongping Cai, Chen Ding, Suling Liu, Yueyin Pan, Wei Jiang, Rongbin Zhou

Article2015

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

Erika Vacchelli, Yuting Ma, Elisa Elena Baracco, Antonella Sistigu, David Enot, Federico Pietrocola, Heng Yang, Sandy Adjemian, Kariman Chaba, Michaëla Semeraro, Michele Signore, Adele De Ninno, Valeria Lucarini, Francesca Peschiaroli, Luca Businaro, Annamaria Gerardino, Gwenola Manic, Thomas Ulas, Patrick Günther, Joachim L. Schultze, Oliver Kepp, Gautier Stoll, Céline Lefèbvre, Claire Mulot, Francesca Castoldi, Sylvie Rusakiewicz, Sylvain Ladoire, Lionel Apétoh, José Manuel Bravo‐San Pedro, Monica Lucattelli, Cécile Delarasse, Valérie Boige, Michel Ducreux, Suzette Delaloge, Christophe Borg, Fabrice André, Giovanna Schiavoni, Ilio Vitale, Pierre Laurent‐Puig, Fabrizio Mattei, Laurence Zitvogel, Guido Guido Kroemer

Article2025

Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma

Annabell Bachem, Michele V. Clarke, Geraldine Kong, И.А. Тарасова, Lachlan Dryburgh, Lindsay Kosack, Ariane R. Lee, L. G. M. Newland, Teagan Wagner, Emma Bawden, Kah Min Yap, Michael D. Wilson, Sven Engel, Kayla R. Wilson, Brendan E. Russ, Kshitij Tandon, Peter K. H. Lau, Grant A. McArthur, Vanessa R. Marcelino, Paul A. Beavis, Stephen T. Turner, Jason Waithman, Timothy P. Stinear, Shahneen Sandhu, Jan Schröder, Thomas Gebhardt, Sammy Bedoui